Evidence map›Paper›PMID 33057138›Full record

ArticleScientific reports2020

A genotyping method combining primer competition PCR with HRM analysis to identify point mutations in Duchenne animal models.

Haizpea Lasa-Fernandez, Laura Mosqueira-Martín, Ainhoa Alzualde, Jaione Lasa-Elgarresta, Ainara Vallejo-Illarramendi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Haizpea Lasa-FernandezGroup of Neurosciences, Dept. Pediatrics, University of the Basque Country UPV/EHU, Hospital Universitario Donostia, Paseo Dr. Begiristain 105, 20014, San Sebastián, Spain.
Laura Mosqueira-MartínGroup of Neurosciences, Dept. Pediatrics, University of the Basque Country UPV/EHU, Hospital Universitario Donostia, Paseo Dr. Begiristain 105, 20014, San Sebastián, Spain.
Ainhoa AlzualdeBIOBIDE, San Sebastián, Spain.
Jaione Lasa-ElgarrestaGroup of Neurosciences, Dept. Pediatrics, University of the Basque Country UPV/EHU, Hospital Universitario Donostia, Paseo Dr. Begiristain 105, 20014, San Sebastián, Spain.
Ainara Vallejo-IllarramendiGroup of Neurosciences, Dept. Pediatrics, University of the Basque Country UPV/EHU, Hospital Universitario Donostia, Paseo Dr. Begiristain 105, 20014, San Sebastián, Spain. ainara.vallejo@ehu.eus.
Instituto de Salud Carlos III · ESBiogipuzkoa Health Research Institute · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dystrophin-null sapje zebrafish is an excellent model for better understanding the pathological mechanisms underlying Duchenne muscular dystrophy, and it has recently arisen as a powerful tool for high-throughput screening of therapeutic candidates for this disease. While dystrophic phenotype in sapje larvae can be easily detected by birefringence, zebrafish genotyping is necessary for drug screening experiments, where the potential rescue of larvae phenotype is the primary outcome. Genotyping is also desirable during colony husbandry since heterozygous progenitors need to be selected. Currently, sapje zebrafish are genotyped through techniques involving sequencing or multi-step PCR, which are often costly, tedious, or require special equipment. Here we report a simple, precise, cost-effective, and versatile PCR genotyping method based on primer competition. Genotypes can be resolved by standard agarose gel electrophoresis and high-resolution melt assay, the latter being especially useful for genotyping a large number of samples. Our approach has shown high sensitivity, specificity, and reproducibility in detecting the A/T point mutation in sapje zebrafish and the C/T mutation in the mdx mouse model of Duchenne. Hence, this method can be applied to other single nucleotide substitutions and may be further optimized to detect small insertions and deletions. Given its robust performance with crude DNA extracts, our strategy may be particularly well-suited for detecting single nucleotide variants in poor-quality samples such as ancient DNA or DNA from formalin-fixed, paraffin-embedded material.

Indexed as

Disease Models, AnimalPoint MutationAnimalsBirefringenceDrug Evaluation, PreclinicalGenotyping TechniquesMice, Inbred C57BLMice, Inbred mdxMolecular Diagnostic TechniquesMuscular Dystrophy, DuchennePolymerase Chain ReactionSensitivity and SpecificityZebrafish

Identifiers

PMID33057138
PMCPMC7560699
OpenAlexW3093275782

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.